Literature DB >> 9577773

Epidemic mycoplasmal conjunctivitis in house finches from eastern North America.

A A Dhondt1, D L Tessaglia, R L Slothower.   

Abstract

In the winter of 1993-94, house finches (Carpodacus mexicanus) with severe conjunctivitis (later shown to be caused by Mycoplasma gallisepticum) were first observed in sub-urban Washington D.C. (USA) and adjacent states. Using a large network of volunteer observers in eastern North America, we were able to track the monthly prevalence of the disease between November 1994 and March 1997. Using the information on 24,864 monthly data forms, we describe the very rapid spread of the conjunctivitis epidemic through the eastern house finch population. The epidemic first expanded mainly north, probably carried along by house finches on their return migration, then mainly toward the southeast, and later west. By March 1997, conjunctivitis had been reported from most of the eastern range of the house finch. The prevalence of the disease seemed to fluctuate seasonally with increases in the fall, probably as a result of dispersing juveniles. House finch numbers decreased throughout winter in areas with cold winters and high conjunctivitis prevalence, suggesting significant mortality associated with the disease.

Entities:  

Mesh:

Year:  1998        PMID: 9577773     DOI: 10.7589/0090-3558-34.2.265

Source DB:  PubMed          Journal:  J Wildl Dis        ISSN: 0090-3558            Impact factor:   1.535


  39 in total

Review 1.  Raccoon rabies in space and time.

Authors:  A Dobson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

2.  Density-dependent decline of host abundance resulting from a new infectious disease.

Authors:  W M Hochachka; A A Dhondt
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

3.  Evidence of spread of the emerging infectious disease, finch trichomonosis, by migrating birds.

Authors:  Becki Lawson; Robert A Robinson; Aleksija Neimanis; Kjell Handeland; Marja Isomursu; Erik O Agren; Inger S Hamnes; Kevin M Tyler; Julian Chantrey; Laura A Hughes; Tom W Pennycott; Vic R Simpson; Shinto K John; Kirsi M Peck; Mike P Toms; Malcolm Bennett; James K Kirkwood; Andrew A Cunningham
Journal:  Ecohealth       Date:  2011-09-21       Impact factor: 3.184

4.  Genetic diversity predicts pathogen resistance and cell-mediated immunocompetence in house finches.

Authors:  Dana M Hawley; Keila V Sydenstricker; George V Kollias; André A Dhondt
Journal:  Biol Lett       Date:  2005-09-22       Impact factor: 3.703

5.  Seasonality and wildlife disease: how seasonal birth, aggregation and variation in immunity affect the dynamics of Mycoplasma gallisepticum in house finches.

Authors:  Parviez R Hosseini; André A Dhondt; Andy Dobson
Journal:  Proc Biol Sci       Date:  2004-12-22       Impact factor: 5.349

6.  Host-pathogen coevolution, secondary sympatry and species diversification.

Authors:  Robert E Ricklefs
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2010-04-12       Impact factor: 6.237

Review 7.  Infectious disease transmission and contact networks in wildlife and livestock.

Authors:  Meggan E Craft
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-05-26       Impact factor: 6.237

8.  Prevalence of blood parasites in eastern versus Western house finches: are eastern birds resistant to infection?

Authors:  Andrew K Davis; Wendy R Hood; Geoffrey E Hill
Journal:  Ecohealth       Date:  2013-06-27       Impact factor: 3.184

9.  Differential house finch leukocyte profiles during experimental infection with Mycoplasma gallisepticum isolates of varying virulence.

Authors:  Natalie M Bale; Ariel E Leon; Dana M Hawley
Journal:  Avian Pathol       Date:  2020-05-18       Impact factor: 3.378

10.  Eye of the Finch: characterization of the ocular microbiome of house finches in relation to mycoplasmal conjunctivitis.

Authors:  Courtney A Thomason; Ariel Leon; Laila T Kirkpatrick; Lisa K Belden; Dana M Hawley
Journal:  Environ Microbiol       Date:  2017-01-25       Impact factor: 5.491

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.